Board approves re-appointment of Managing Director and Independent Director

Management Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.0%Reaction day

₹10.00

prior close

₹9.85

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%-1.3% vs market

Gems, Jewellery And Watches peers, median of 36sector-0.5%-0.5% vs sector

On the reaction day the stock moved 1.3 pts less than Nifty Microcap 250 and 0.5 pts less than its Gems, Jewellery And Watches peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.5

10m

+1.5

15m

+2.0

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.0+0.3-1.3-0.5-0.5

Next day

+0.9-0.9+1.8-0.9+1.8

+0.4-1.5+1.9-1.0+1.4

+0.0-1.1+1.1-1.9+1.9

-0.3+0.2-0.5-0.2-0.1

-0.9-1.1+0.2-0.8-0.1

+8.6-1.2+9.8+0.0+8.6

15d

+4.4+3.1+1.3-2.4+6.8

+0.0+4.5-4.5-3.3+3.3

+0.3+4.5-4.2+0.9-0.6

-0.1-2.2+2.1+2.4-2.5

UpDownMarket · Nifty Microcap 250Sector · Gems, Jewellery And Watches peers, median of 36Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board meeting on July 20, 2026 approved re-appointment of Mr. Mahendra Ramniklal Shah as Managing Director for 5 years (August 10, 2026 to August 9, 2031) and Mr. Sanjay Chunilal Vibhakar as Independent Director for a second 5-year term till June 20, 2031. Both need shareholder approval at the upcoming AGM. Mr. Shah has 30 plus years in jewellery sourcing and supply chain, while Mr. Vibhakar has 25 plus years across gold, jewellery and media.

Likely market impact

Continuity at top leadership and board. Routine re-appointments, pending shareholder vote at the next AGM. No major governance red flags reported.